Astoriom, a global leader in scientific research and consumer product sample stability and biorepository storage, has expanded its sample management capabilities in the US with the acquisition of Precision Stability Storage. This acquisition marks a strategic expansion of Astoriom's footprint in North America, strengthening its presence in high-growth regions for biopharmaceutical, biotechnology and medical technology innovation. With increased capacity, broader geographic coverage and faster access to GxP stability storage, Astoriom's global customers will gain local access to reliable and compliant solutions to advance scientific discovery and product innovation.
Precision Stability Storage sites in Wilson (North Carolina), Fort Lauderdale (Florida) and Hopedale (Massachusetts) add to Astoriom's extensive portfolio of global sample storage facilities, strengthening its current capabilities to address the growing need for comprehensive, cost-effective and scalable solutions. The state-of-the-art facilities provide the highest standards of offsite stability storage, quality and compliance for products that require ICH-specified environmental conditions and storage of temperature-sensitive biological materials. This includes long-term and intermediate conditions (25 °C /40 % relative humidity (RH), 25 °C /60 % RH, 30 °C /65 % RH, 30 °C /75 % RH, 30 °C /35 % RH), accelerated storage (40 °C /< 25 % RH, 40 °C /75 % RH), refrigerated and freezer storage conditions (2-8 °C, -20 °C, -80 °C, -196 °C) as well as ambient storage conditions (15-30 °C). These capabilities will further enable Astoriom to secure, protect and preserve the viability and integrity of samples and products for its customers with enhanced geographic reach.
The acquisition is a critical step in Astoriom's global M&A-driven expansion strategy. It follows the acquisition of North Carolina-based Flagship Biosciences' biorepository solutions and Nottingham-based MTS Cryo Stores and Cool Repair Scientific UK, as well as the launch of its cryosuite and expansion of its Tramore site in Ireland.
This acquisition is testament to Precision Stability Storage's exceptional standards of storage excellence, compliance and security, offering the utmost-quality equipment and facilities available for temperature and humidity control to ensure the preservation of vital stability studies. Together, we've reinforced our position as a trusted global partner that organizations can depend on to maintain the integrity of their valuable sample assets."
Lori A. Ball, Board Member, Astoriom
"Precision Stability Storage has been proud to play a crucial role in ensuring outstanding storage and protection of products and samples for various industries," added Clay Hile, Managing Director, Precision Stability Storage. "Astoriom's expertise and dedication to safeguarding every sample will ensure this continues, while also providing customers with access to Astoriom's global stability storage and biorepository solutions."
"Astoriom continues to expand into key markets, demonstrating both growth and long-term demand for our integrated services in the US. This acquisition reinforces our unwavering commitment to providing global customers with local access to world-class stability storage facilities. Supporting our customers with closer proximity and greater flexibility will ensure we remain the trusted leader in safeguarding critical scientific research and consumer product samples," said Will Edwards, CEO, Astoriom. "I'd like to express our sincere appreciation and thanks to both Lori Ball and Clay Hile for their leadership in bringing this acquisition to completion. The tremendous efforts they invested in navigating this process have been instrumental in shaping the company's future and we look forward to building upon the strong foundation they have put in place."
Research shows GLP-1 drugs safeguard vision despite small retinopathy risk